Genetic component in ~40–50% of OCD cases
Twin studies suggest that roughly 40 to 50% of OCD cases have an identifiable genetic component, though genes cannot be controlled.
Snapshot · Huberman Lab
Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)
Explore episode
Jul 9, 2026
Where this was said
Genetic Component of OCD
At 6:55 · chapter starts 6:40
Huberman explores the hereditary dimension of OCD through the lens of twin studies — comparing identical twins (including monocorionic pairs sharing the same gestational sac), fraternal twins, and non-twin populations. The broad conclusion: approximately 40 to 50% of OCD cases have some identifiable genetic component. Huberman acknowledges this is interesting but tempers expectations about its clinical utility — people can't choose their genes or their parents. What this data does usefully establish is that OCD is not purely a product of upbringing or environment; biology loads the gun for about half of sufferers. For the other half, the disorder appears to arise through other pathways, underscoring the importance of neurological and behavioral mechanisms as intervention targets.
The Genetics of OCD: Nature's 40–50% Contribution
About 40 to 50% of OCD cases have a genetic component, as revealed by twin studies examining identical and fraternal twins. But genes aren't destiny — a substantial portion of OCD arises without any identifiable inherited factor.
Cortico-striatal-thalamic loop underlies OCD
Dozens to hundreds of neuroimaging studies point to the cortico-striatal-thalamic loop as the primary neural circuit generating obsessions and compulsions in OCD.
The Cortico-Striatal-Thalamic Loop: OCD's Neural Engine
Dozens to hundreds of neuroimaging studies converge on one circuit: the cortico-striatal-thalamic loop. The cortex processes perception, the striatum governs go/no-go action, and the thalamus gates what reaches consciousness. When this loop misfires, intrusive thoughts and compulsive behaviors emerge.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
